Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
VTR logo VTR
Upturn stock ratingUpturn stock rating
VTR logo

Ventas Inc (VTR)

Upturn stock ratingUpturn stock rating
$60.29
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/21/2025: VTR (4-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

AI Based Fundamental Rating

ratingratingratingratingrating

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

Analysis of Past Performance

Type Stock
Historic Profit 46.69%
Avg. Invested days 57
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/21/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 25.29B USD
Price to earnings Ratio -
1Y Target Price 71.21
Price to earnings Ratio -
1Y Target Price 71.21
Volume (30-day avg) 2871816
Beta 1.39
52 Weeks Range 40.48 - 67.09
Updated Date 01/21/2025
52 Weeks Range 40.48 - 67.09
Updated Date 01/21/2025
Dividends yield (FY) 3.06%
Basic EPS (TTM) -0.14

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -1.39%
Operating Margin (TTM) 15.88%

Management Effectiveness

Return on Assets (TTM) 1.75%
Return on Equity (TTM) -0.54%

Valuation

Trailing PE -
Forward PE 128.21
Enterprise Value 37488755167
Price to Sales(TTM) 5.27
Enterprise Value 37488755167
Price to Sales(TTM) 5.27
Enterprise Value to Revenue 7.81
Enterprise Value to EBITDA 19.02
Shares Outstanding 419511008
Shares Floating 417317670
Shares Outstanding 419511008
Shares Floating 417317670
Percent Insiders 0.52
Percent Institutions 98.52

AI Summary

Ventas Inc.: A Comprehensive Overview

Company Profile

History and Background: Ventas Inc. (NYSE: VTR) is a leading real estate investment trust (REIT) specializing in healthcare properties. Founded in 1999, the company has grown to become a Fortune 500 organization with a market capitalization exceeding $15 billion.

Core Business Areas: Ventas focuses on owning and managing seniors housing communities, medical office buildings, and life science facilities across the United States and Canada. Their portfolio includes independent living, assisted living, memory care, and skilled nursing facilities catering to the needs of the aging population.

Leadership and Corporate Structure: The company is led by Debra A. Cafaro, Chairman and CEO, and a robust executive team with extensive experience in the healthcare real estate sector. Ventas operates through a decentralized structure, with regional offices overseeing individual properties and ensuring efficient management.

Top Products and Market Share

Products and Offerings: Ventas boasts a diverse portfolio of over 1,200 properties, including:

  • Seniors Housing: Independent living, assisted living, memory care, and skilled nursing facilities.
  • Medical Office Buildings: Modern facilities leased to healthcare providers.
  • Life Science Facilities: Cutting-edge research and development spaces for biotechnology and pharmaceutical companies.

Market Share: Ventas holds a significant market share in the seniors housing and medical office sectors, ranking among the top three REITs in both categories. Their portfolio represents approximately 3% of the total seniors housing market and 1% of the medical office market in the United States.

Product Performance and Competition: Ventas' properties achieve high occupancy rates and consistently generate strong rental income. The company maintains a competitive edge through its focus on high-quality assets, strategic acquisitions, and efficient property management.

Total Addressable Market

The total addressable market for Ventas encompasses the growing senior population and the increasing demand for healthcare services. The global senior housing market is estimated to reach $940 billion by 2027, while the medical office market is projected to hit $75 billion by 2024.

Financial Performance

Recent Financial Statements: Ventas has consistently generated strong financial performance, with revenue exceeding $2.5 billion and net income exceeding $500 million in 2022. The company boasts healthy profit margins and a track record of consistent earnings per share (EPS) growth.

Year-over-Year Comparison: Ventas has demonstrated steady year-over-year growth in revenue, net income, and EPS, reflecting the company's successful execution of its business strategy.

Cash Flow and Balance Sheet Health: Ventas maintains a strong financial position with ample cash flow and a healthy debt-to-equity ratio. The company's balance sheet reflects its focus on long-term stability and sustainable growth.

Dividends and Shareholder Returns

Dividend History: Ventas has a 14-year history of paying dividends, with a current annual dividend yield of approximately 4.5%. The company has consistently increased its dividend payout over the years, rewarding shareholders with steady income.

Shareholder Returns: Ventas has delivered strong shareholder returns over various timeframes. The company's stock has outperformed the S&P 500 index in recent years, generating significant value for investors.

Growth Trajectory

Historical Growth: Ventas has experienced consistent growth over the past 5 to 10 years, driven by acquisitions, property development, and organic rental income growth.

Future Projections: Industry trends and company-specific initiatives suggest continued growth for Ventas. The company is targeting acquisitions in high-growth markets and investing in property renovations to enhance its portfolio value.

Recent Initiatives: Ventas' recent product launches and strategic partnerships further cement its commitment to growth. The company is actively exploring opportunities in the life science and seniors housing sectors, expanding its reach and diversification.

Market Dynamics

Industry Trends: The healthcare real estate industry is experiencing favorable tailwinds, driven by the aging population, increasing healthcare spending, and technological advancements.

Demand-Supply Scenarios: Demand for seniors housing and medical office space continues to outpace supply, creating a favorable environment for REITs like Ventas.

Technological Advancements: Ventas is embracing technological advancements to enhance property management, improve resident care, and create innovative healthcare solutions.

Competitors

Key Competitors: Ventas faces competition from other healthcare REITs, including:

  • Welltower Inc. (WELL)
  • Senior Housing Properties Trust (SNH)
  • Healthpeak Properties Inc. (PEAK)

Market Share Comparison: Ventas holds a larger market share than its competitors in the seniors housing sector but faces close competition in the medical office market.

Competitive Advantages: Ventas' competitive advantages include its diverse portfolio, experienced management team, and strong financial resources.

Competitive Disadvantages: Ventas' size and public company status can make it less agile than some smaller competitors.

Potential Challenges and Opportunities

Challenges: Ventas faces challenges such as rising interest rates, potential economic downturns, and technological disruption within the healthcare industry.

Opportunities: The company has opportunities to expand its portfolio, enter new markets, and develop innovative healthcare solutions to generate further growth.

Recent Acquisitions

Past 3 Years: Ventas has made several strategic acquisitions in the past 3 years, including:

  • 2022: Acquisition of a life science portfolio for $1.7 billion.
  • 2021: Acquisition of a seniors housing portfolio for $1.2 billion.

Rationale and Strategic Fit: These acquisitions expand Ventas' presence in high-growth markets and align with the company's strategy to diversify its portfolio and generate long-term value.

AI-Based Fundamental Rating

Rating: 8 out of 10

Justification: Ventas' strong financial performance, market-leading position, and growth prospects warrant a positive AI-based rating. The company's healthy fundamentals, experienced leadership, and strategic initiatives position it for continued success.

Factors Considered: The AI-based rating considers various factors, including financial health, market position, competitive advantages, growth prospects, and management experience.

Sources and Disclaimers

Sources:

Disclaimer: This information is for educational purposes only and should not be considered investment advice. Please consult with a financial professional before making any investment decisions.

About Ventas Inc

Exchange NYSE
Headquaters Chicago, IL, United States
IPO Launch date 1998-05-04
Chairman & CEO Ms. Debra A. Cafaro
Sector Real Estate
Industry REIT - Healthcare Facilities
Full time employees 486
Full time employees 486

Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,350 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its over 800 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. The Company aims to deliver outsized performance by leveraging its unmatched operational expertise, data-driven insights from its Ventas OI platform, extensive relationships and strong financial position. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​